Adults with type 1 diabetes may be able to maintain their glucose levels in target range longer, particularly during the day, by using an artificial pancreas with rapid-acting insulin and pramlintide, according to findings published in Diabetes Care. “Since adding pramlintide to the artificial pancreas targets postprandial hyperglycemia, the rapid insulin-and-pramlintide artificial pancreas may be […]
